A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
Status:
Completed
Trial end date:
2008-06-27
Target enrollment:
Participant gender:
Summary
Motilin is a peptide whose action is controlled by motilin receptors located in the gut.
Action of Motilin at motilin receptors increases the gastric emptying rate (rate of emptying
of food and fluid from the stomach). Compounds which stimulate motilin receptors therefore
provide a potential approach to the treatment of a range of clinical conditions where delayed
gastric emptying may contribute to symptoms, such as enteral feeding intolerance
(post-operative or intensive care patients), gastroparesis, diabetic gastroparesis, and
functional dyspepsia.
This study is the First Time In Human study for the motilin receptor agonist, GSK962040.